contextualized insights from atlas on the use of tkis in adjuvant mrcc treatment
Published 2 years ago • 9 plays • Length 4:23Download video MP4
Download video MP3
Similar videos
-
7:55
mrcc: identifying and managing aes in tkis and io therapy
-
3:05
focus on kidney: carmena and renal cell carcinoma
-
6:07
sequential use of immune checkpoint inhibitors in renal cell carcinoma
-
41:21
the role of tyrosine kinase inhibitors and mtor inhibitors
-
4:47
imdc criteria and targeted therapy in mrcc
-
1:54
dr. figlin on tki therapy options in renal cell carcinoma
-
2:03
dr. george on dosing tkis in rcc
-
10:24
the typical prognosis of aggressive renal cell cancer
-
25:28
systemic treatment of metastatic renal cell cancer: what is state of the art in 2020? - l. albiges
-
4:44
cellular neurothekeoma (mimic of spitz nevus, sarcoidosis, & granulomas) pathology dermpath
-
59:55
renal cell carcinoma: past, present, and future
-
2:19
dr. sweis on the management of tki-associated adverse events in kidney cancer
-
0:10
copy of dr. grigg on frontline tyrosine kinase inhibitors in rcc
-
0:57
dr. marks on the role of tkis in her2-positive breast cancer
-
4:38
determining progression in metastatic renal cell carcinoma
-
10:20
high-resolution atlas of the human kidney
-
1:35
dr. grigg on immunotherapy/tki combinations in rcc
-
0:53
dr. tsao on rationale for staging renal cell carcinoma
-
5:50
first-line considerations in metastatic renal cell carcinoma
-
44:08
recent advances in the diagnosis & classification of renal cell carcinomas
-
2:01
the emerging role of pet tracers in managing renal cell carcinoma